Alaya.bio
Biotechnology Research
Cambridge, United States
22 employees
- Employees
- 22
- Contacts
- 2
- Emails
- 2
- Phones
- 1
Alaya.bio Overview
- Headquarters
- Cambridge, United States
- Website
- www.alaya.bio
- Industry
- Biotechnology Research
- Employees
- 22
- Founded
- 2022
- Funding
- 3.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Alaya.bio
At Alaya.bio, we're developing a revolutionary targeting polymeric nanoparticle that enhances the transduction efficiency of quiescent cells such as T-cells, NK-cells, and stem cells. Our platform eliminates the need for activation factors or cytokines, resulting in reduced exhaustion of transduced cells while preserving their naive and memory phenotypes, leading to better clinical outcomes.
Alaya.bio Contact Details
- People in AeroLeads
- 2
- With contact data
- 2
- Email contacts
- 2
- 100.0% coverage
- Phone contacts
- 1
- 50.0% coverage
Alaya.bio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Loïc Vincent | Cso - Scientific Advisor - Board Member | United States |
Email
|
| Renaud Vaillant | Board Member and Managing Director | Greater Paris Metropolitan Region, France |
Email
Phone
|
Compare Similar Companies to Alaya.bio
Viralgen
Biotechnology Research
Century Therapeutics, Inc
Biotechnology
Kelonia Therapeutics
Biotechnology
Interius BioTherapeutics
Biotechnology Research
Myeloid Therapeutics
Biotechnology
Carisma Therapeutics
Biotechnology Research
CellFE
Biotechnology
Genprex, Inc.
Biotechnology
Nanocell Therapeutics
Pharmaceutical Manufacturing
Ixaka
Biotechnology Research